Contributor

Doug Peddicord

Executive Director, Association of Clinical Research Organizations

lfarnsworth@cvic.com

Biography provided by participant

Douglas Peddicord, Ph.D., is Executive Director of the Association of Clinical Research Organizations (ACRO). With policy expertise in the conduct and regulatory oversight of clinical trials, Dr. Peddicord has represented the association since it was founded in 2002. As the voice of the CRO industry around the world, ACRO actively participates in policy discussions around regulations, legislation or other policy initiatives that impact the CRO industry in both the United States and internationally. Dr. Peddicord speaks frequently on the vital role of the CRO in the clinical research enterprise and the strong commitment of ACRO's members to the safe and ethical conduct of clinical research and to the well-being of study participants, as well as on broader issues relating to the conduct of clinical research, including health information privacy, financial conflicts of interest, and the globalization of clinical trials. Following a career as a clinical psychologist, Dr. Peddicord came to Capitol Hill as an American Association for the Advancement of Science (AAAS) Congressional Fellow in 1994. He worked on Medicare and a range of other healthcare issues as Legislative Assistant for Health for now-Senator Ben Cardin (D-MD), who at the time served in the House as a member of the Ways and Means Health Subcommittee. Later, Dr. Peddicord was a policy advisor to the Chairman of the Maryland State Health Care Access and Cost Commission. Dr. Peddicord is a current member of the Clinical Trials Transformation Initiative (CTTI) Steering Committee. After attending Amherst College, Dr. Peddicord received his B.A. from the University of Bridgeport. He holds a Master's degree and a Ph.D. in Clinical Psychology from Adelphi University.

Recent Responses

January 19, 2012 02:50 PM

If I Were the President's Speechwriter

Whether you agree with the President or not, health reform is one of the most important issues facing our country and the President should absolutely defend this accomplishment in his speech and use this chance to make a pitch in front of the SCOTUS.

In fact, if I were the President’s speechwriter, his remarks concerning health care would look something like this:

“As we begin implementing the Patient Protection and Affordable Care Act, it’s important to remind the American people that we have guaranteed that no one will be rejected for health insurance, even if they have, what the insurance industry liked to call ‘pre-existing conditions’. Through this plan, we are making healthcare more accessible and affordable through insurance exchanges and accountable care organizations that ensure physicians are working together to provide patients quality care and not worrying about how many tests they should run. We also closed the so-called ‘donut hole’ under Medicare Part D to lower the cost of prescriptions for seniors.

December 21, 2011 12:00 PM

Medical Research is More than NIH

I resolve that I will not think that funding the NIH fulfills all of our medical research needs and that I will keep research in mind when considering all healthcare policies, including “Sunshine”, EHR adoption, comparative effectiveness, FDA appropriations, HIPAA, tax policy and medical liability reform.